TELA
TELA
NASDAQ · Health Care

Tela Bio Inc

$0.98
-0.01 (-1.44%)
As of May 16, 2:23 AM ET ·
Financial Highlights (FY 2026)
Revenue
71.00M
Net Income
-34,343,138
Gross Margin
67.7%
Profit Margin
-48.4%
Rev Growth
+24.7%
D/E Ratio
8.82
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.7% 67.7% 28.2% 28.2%
Operating Margin -43.2% -38.8% 18.2% 16.6%
Profit Margin -48.4% -46.0% 17.0% 16.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 71.00M 56.95M 7.47M 7.60M
Gross Profit 48.06M 38.55M 2.11M 2.15M
Operating Income -30,643,199 -22,119,729 1.36M 1.26M
Net Income -34,343,138 -24,790,523 1.27M 1.28M
Gross Margin 67.7% 67.7% 28.2% 28.2%
Operating Margin -43.2% -38.8% 18.2% 16.6%
Profit Margin -48.4% -46.0% 17.0% 16.9%
Rev Growth +24.7% +24.7% +18.1% +22.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 18.19M 18.19M 9.64M 8.55M
Total Equity 2.06M 2.06M 26.51M 24.38M
D/E Ratio 8.82 8.82 0.36 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -28,945,232 -22,054,836 2.01M 2.00M
Free Cash Flow 1.14M 1.46M